Animal health medications benefit from serialization technology

Serialization technology protects global pharmaceutical and biotech maker protect its flea-and-tick medications.

With a vision to ensure safety and sanctity of their animal health medications, a global pharmaceutical and biotech manufacturer has selected and implemented Xyntek and Antares serialization technology to protect their animal health brand.

The product, which was serialized and aggregated by the Xyntek and Antares technology, is an animal medication used to prevent fleas and ticks in household pets.

The technology features the Antares Tracking System (ATS) software platform and pre-engineered Print & Check modules. The technology not only serializes at the smallest unit of sale, but also provides several layers of aggregation and serialization at the bundle/tray, and case.

The serialization technology enables the client to efficiently and reliably track and trace their animal care product through the entire supply chain and ensures that only authentic and quality product will reach its consumers. To date, there have been a handful of instances where diverged or expired product has been identified in the market place. Using the Xyntek and Antares technology, the client is able to track where these packages originated from and where they have shipped to, and as a result remove bad and diverted products from the shelves, and protect their consumers and brand image.

According to Mac Hashemian, Xyntek CEO,"Product Serialization is the first step to ensure compliance with the Drug Quality and Security Act (DQSA) and other existing and emerging global track-and-trace regulations that require product visibility and traceability throughout the prescription drug supply chain. However, these technologies have value outside of just complying with the regulatory requirements. Added benefits such as recall management, returns management, diverted products, etc., bring value to our clients’ products that should not be restricted to just prescription pharmaceuticals. A lot of return on investments can be gained by applying the same technologies for non-prescription products, including animal healthcare products and consumer healthcare products that are not currently under any federal regulation for track and trace. “

Companies in this article
More in Home